Skip to main content
Retour
Watch Compare

BiomX Inc.

Qualité des données : 83%
PHGE
NYSE Manufacturing Chemicals
2,99 €
▲ 0,09 € (3,10%)
Cap. Boursière: 19,57 M
Prix
2,99 €
Cap. Boursière
19,57 M
Fourchette du Jour
2,50 € — 3,00 €
Fourchette 52 Semaines
1,50 € — 14,71 €
Volume
119 428
Ouverture 2,85 €
Moyenne 50J / 200J
5,25 €
43,10% below
Moyenne 50J / 200J
6,95 €
56,98% below

Quick Summary

Points Clés

Negative free cash flow of -26,39 M

Croissance

Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Qualité

Return on Equity
-244,21%
En dessous de la moyenne du secteur (-51,02%)
ROIC-124,25%
Net MarginN/A
Op. MarginN/A

Sécurité

Debt / Equity
N/A
Current Ratio1,70
Interest Coverage-48,78

Valorisation

PE (TTM)
-0,54
Au-dessus de la moyenne du secteur (-1,98)
P/B Ratio1,87
EV/EBITDAN/A
Dividend YieldN/A

Historique des Prix

Tendances Financières

Comparaison Sectorielle

vs médiane du secteur Manufacturing (44 pairs)
Métrique Action Médiane du Secteur
P/E -0,5 -2,0
P/B 1,9 5,1
ROE % -244,2 -51,0
Net Margin % — -150,2
Rev Growth 5Y % — 9,3
D/E — 0,3

All Fundamental Metrics
Growth
Revenue Growth (1Y) N/A Revenue Growth (3Y) N/A
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) N/A Net Income (TTM) -36,20 M
ROE -244,21% ROA -112,74%
Gross Margin N/A Operating Margin N/A
Net Margin N/A Free Cash Flow (TTM) -26,39 M
ROIC -124,25% FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio 1,70
Interest Coverage -48,78 Asset Turnover N/A
Working Capital 3,64 M Tangible Book Value 10,49 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -0,54 Forward P/E N/A
P/B Ratio 1,87 P/S Ratio N/A
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -134,89%
Market Cap 19,57 M Enterprise Value 12,64 M
Per Share
EPS (Diluted TTM) 22,19 Revenue / Share N/A
FCF / Share -4,03 OCF / Share -4,03
EPS CAGR (1Y) 560,42% EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue N/A FCF Conversion 72,91%
SBC-Adj. FCF -29,01 M Growth Momentum N/A

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue — — — — —
Net Income -36,20 M -17,73 M -26,17 M -28,32 M -36,23 M
EPS (Diluted) 22,19 3,36 0,51 0,95 —
Gross Profit — — — — —
Operating Income -41,47 M -44,52 M -25,35 M -27,22 M -35,46 M
EBITDA — — — — —
R&D Expenses 21,29 M 24,66 M 16,70 M 16,24 M 22,68 M
SG&A Expenses — — — — —
D&A — — 871 000,0 2,52 M 986 000,0
Interest Expense 850 000,0 850 000,0 2,40 M 2,07 M 983 000,0
Income Tax 7 000,0 13 000,0 23 000,0 65 000,0 67 000,0

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 5,78 M 43,23 M 25,03 M 45,53 M 77,99 M
Total Liabilities — — — — —
Shareholders' Equity -1,30 M 24,15 M 3,08 M 21,04 M 47,54 M
Total Debt — 5,40 M 11,19 M 15,00 M 15,00 M
Cash & Equivalents 4,36 M 16,86 M 14,91 M 31,33 M 62,10 M
Current Assets 5,58 M 20,52 M 17,63 M 36,88 M 66,64 M
Current Liabilities 6,38 M 8,27 M 11,18 M 7,94 M 11,04 M